<?xml version="1.0" encoding="UTF-8"?>
<p>NMDAR antibodies are of interest in schizophrenia because of their links to the glutamate/NMDAR hypofunction hypothesis of psychotic disorders: NMDAR antibodies found in patients with schizophrenia can disrupt NMDAR dynamics 
 <italic>in vivo</italic> (
 <xref rid="B189" ref-type="bibr">189</xref>, 
 <xref rid="B190" ref-type="bibr">190</xref>) providing 
 <italic>prima facie</italic> support for the NMDAR hypofunction hypothesis. Crucially, Hammer et al. (
 <xref rid="B191" ref-type="bibr">191</xref>) reported the presence of influenza virus A or B IgG was significantly associated with NMDAR antibody seropositivity in a large cohort of adult patients with psychotic disorders and disease and healthy controls, a finding that was subsequently replicated in an independent cohort (
 <xref rid="B192" ref-type="bibr">192</xref>).
</p>
